NOILE-IMMUNE BIOTECH INC revenue for the last year amounted to 316.00 M JPY, the most of which — 316.82 M JPY — came from its highest performing source at the moment, Cancer Immunotherapy Drug, the year earlier bringing 625.78 M JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought NOILE-IMMUNE BIOTECH INC 316.82 M JPY, and the year before that — 613.59 M JPY.